Follow the Strides Pharma Science Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Strides Pharma Science Limited has recorded 39 public disclosures. Market capitalisation: €98.9bn. The latest transaction was filed on 24 March 2022 (Purchase). Among the most active insiders: Pronomz Ventures LLP. All data is openly available.
39
Insider Decl.
n/a
Thresholds
€4m
23 ops.
Buy Volume
€3m
16 ops.
Sell Volume
11Σ signal
Buys €4m€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,783 of 28,752 companies
64.8
score / 100
Value
58
Quality
72
FCF yld2.9%
Earn yld5.6%
EV/EBITDA11.4x
ROE20%
Gross mgn53%
Net mgn12%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Strides Pharma Science Limited is an Indian pharmaceutical company focused on the manufacturing of generic drugs and healthcare products. It primarily operates on the Bombay Stock Exchange.